(Total Views: 578)
Posted On: 06/15/2022 5:53:10 PM
Post# of 148903
i think the NASH data at this conference could be the catalyst for partnership discussions - which would represent a sea change for the company. I can't say i fully understood the data that was released on the board, but i'm going with the position that it will be incredibly well received at this conference. Loving the fact that we will be presenting vs. just a poster. Sure would love to see a replay of the presentation and curious if it will be made available.
on oncology, i think there is a chance that Pestell gets re-engaged. I know some people don't like him, but he is incredibly impressive in my opinion - and motivated by shares to make this thing work. I think he's a key asset for us, and i for one was excited to see him come back.
moving down the line, gestalt made a great point about the HIV potential - that this indication alone could send us to $10-20 / share. what i have no clarity on whatsoever is where we are with the BLA. Are we close?
Regardless, i'm as bullish as i have ever been, and have added as many shares as i can afford.
on oncology, i think there is a chance that Pestell gets re-engaged. I know some people don't like him, but he is incredibly impressive in my opinion - and motivated by shares to make this thing work. I think he's a key asset for us, and i for one was excited to see him come back.
moving down the line, gestalt made a great point about the HIV potential - that this indication alone could send us to $10-20 / share. what i have no clarity on whatsoever is where we are with the BLA. Are we close?
Regardless, i'm as bullish as i have ever been, and have added as many shares as i can afford.
(2)
(0)Scroll down for more posts ▼
